ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $959 | +42.9% | 5,380 | +26.3% | 0.12% | +80.6% |
| Q4 2022 | $671 | -100.0% | 4,260 | -62.4% | 0.07% | -77.5% |
| Q1 2022 | $2,525,000 | +649.3% | 11,340 | +698.6% | 0.30% | +705.4% |
| Q4 2021 | $337,000 | +1.8% | 1,420 | -11.8% | 0.04% | +12.1% |
| Q2 2021 | $331,000 | -73.4% | 1,610 | -73.5% | 0.03% | -76.6% |
| Q1 2021 | $1,246,000 | +129.9% | 6,065 | +104.3% | 0.14% | +62.1% |
| Q3 2020 | $542,000 | -8.3% | 2,968 | +42.1% | 0.09% | +6.1% |
| Q3 2018 | $591,000 | -47.1% | 2,089 | -45.1% | 0.08% | -51.2% |
| Q2 2018 | $1,118,000 | +161.2% | 3,807 | +124.5% | 0.17% | +162.5% |
| Q1 2018 | $428,000 | +48.1% | 1,696 | -13.5% | 0.06% | -17.9% |
| Q4 2016 | $289,000 | +33.2% | 1,960 | -45.0% | 0.08% | -78.6% |
| Q4 2012 | $217,000 | – | 3,564 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |